- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy ; volume:46 ; number:3-4 ; day:16 ; month:7 ; year:2024 ; pages:1-19 ; date:8.2024
Seminars in immunopathology ; 46, Heft 3-4 (16.7.2024), 1-19, 8.2024
- Creator
-
Hughes, Andrew D.
Teachey, David T.
Diorio, Caroline
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00281-024-01013-w
- URN
-
urn:nbn:de:101:1-2411192108362.018092367657
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hughes, Andrew D.
- Teachey, David T.
- Diorio, Caroline
- SpringerLink (Online service)
Other Objects (12)
CART Cell Toxicities: New Insight into Mechanisms and Management
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
CARt
CARt
CART
CARt
"CARt*
CART Cell Toxicities: New Insight into Mechanisms and Management
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
CARt
CARt
CART
CARt
"CARt*
CART Cell Toxicities: New Insight into Mechanisms and Management
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
CARt
CARt
CART
CARt